Substance Use Risk and Solution-Focused Approach

December 9, 2024 updated by: Ufuk DOĞAN

The Effect of Solution-Focused Approach on the Self-Control and Substance Use Risk Level of Nursing Students with Substance Use Risk

Although substance abuse is the subject of serious struggles on the basis of individuals and countries, its rate of spread cannot be stopped and it creates an agenda with new people added every day. Substance addiction, which not only creates physiological problems in individuals, but also affects human health in every aspect with psychological and social problems, adversely affects the health status of individuals as well as their families and environments. The best way to get rid of addiction is to never start. Therefore, our study focused on preventing addiction, not addiction. After applying the Substance Use Tendency Scale and Self-Control Scale to university students, an intervention and control group will be formed. Solution Focused Approach program will be applied to the intervention group. At the end of the program, post-tests will be applied to the intervention and control groups.

Study Overview

Status

Completed

Conditions

Detailed Description

First of all, the Substance Use Tendency Scale (MDAS) and personal information form will be applied to the nursing students of the Faculty of Health Sciences, which consists of 750 people. A high score in any of the BCAS subscales indicates a tendency towards addiction. After this, students with a tendency will be determined. After the power analysis is performed, the appropriate number of samples will be determined. Finally, participants will be assigned to the intervention/control group by randomization. A substance use prevention psychoeducation program based on a solution-focused approach will be applied to the experimental group in 7 sessions for 6 weeks. No intervention will be made to the control group. At the end of psychoeducation, posttests will be collected from the experimental and control groups.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Elazığ, Turkey, 23000
        • Ufuk Doğan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

The criteria for inclusion in the research at the stage;

  • Being an active student registered as a nursing student at Fırat University
  • Volunteering to participate in the research.
  • Not receiving any psychological counseling and treatment
  • Getting a sufficiently high score in any of the sub-dimensions according to the Substance Use Risk Profile Scale
  • Not being diagnosed with substance abuse or substance abuse Exclusion criteria from the study at Phase I;
  • Not complying with the principle of volunteering
  • Getting a low score in all sub-dimensions according to the Substance Use Risk Profile Scale
  • Being diagnosed with substance abuse or substance abuse

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Experimental: Experimental Group
The "short solution-oriented program" intervention group will be applied for 6 weeks, a total of 7 lesson hours.
It will be a psychoeducational approach aimed at developing preventive and protective properties against addiction.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Students' Substance Use Risk Levels
Time Frame: 3 month period
The scale developed by Woicik et al. (2009) and showing good psychometric properties in non-clinical samples was validated and reliability-tested in Turkish by Uygun et al. (2019). It is a 23-item (4-point Likert scale: 1 strongly disagree, 4 strongly agree) measurement tool. The scale has four subdimensions: hopelessness/self-discontent, impulsivity, sensation seeking, and anxiety sensitivity. The Cronbach's alpha value is determined to be 0.728. If at least one of the subscale scores is found to be high, it indicates a high risk of substance use in the individua
3 month period
"Changes in the Self-Control Levels of Students at Risk of Substance Use
Time Frame: 3 month period
The Self-Control Scale (SCS): The scale was developed by Rosenbaum in 1980. It measures how well individuals can use their existing control behaviors to solve problems they encounter in daily life. The Turkish validity and reliability studies were conducted by Duyan, Gülden, and Gelbal in 2012. The scale aims to estimate individuals' mental skills in controlling psychological and physiological responses such as anxiety, anger, and pain; delaying short-term satisfaction; initiating problem-solving processes; and self-efficacy perception. The scale consists of 3 sub-dimensions: Restorative Self-Control, Experiential Self-Control, and Renewing Self-Control, with a total of 36 items. Participants are asked to select one of the options prepared in a 6-point Likert type ranging from "Completely fits me +3" to "Completely does not fit me -3" in response to the questions. Higher scores on the scale indicate higher levels of self-control. The Cronbach's Alpha value was found to be 0.809.
3 month period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Ufuk Doğan, PhD, Hasan Kalyoncu University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2023

Primary Completion (Actual)

November 1, 2023

Study Completion (Actual)

June 30, 2024

Study Registration Dates

First Submitted

June 29, 2024

First Submitted That Met QC Criteria

December 9, 2024

First Posted (Estimated)

December 13, 2024

Study Record Updates

Last Update Posted (Estimated)

December 13, 2024

Last Update Submitted That Met QC Criteria

December 9, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Self Efficacy

Clinical Trials on Short Solution Focused Approach Program

Subscribe